Goldman SachsGSPAST TOP PICKFeb 05, 2020Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
(A Top Pick Feb 12/19, Up 28%) It has rallied well. They are transitioning more into retail banking. They are behind the Apple credit card. As they move into the retail banking space, they have to increase reserve holdings, which has created a headwind. However, he thinks they are beyond that now. He continues to remain constructive on them.